The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?
EJNMMI Radiopharm Chem
.
2019 Jan 11;4(1):2.
doi: 10.1186/s41181-019-0055-6.
Authors
Iván Peñuelas
1
,
Daniëlle J Vugts
2
,
Clemens Decristoforo
3
,
Philip H Elsinga
4
Affiliations
1
Radiopharmacy Unit, Department of Nuclear Medicine, Clínica Universidad de Navarra (UNAV), IdiSNA, Pamplona, Spain. ipenuelas@unav.es.
2
Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, the Netherlands.
3
Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.
4
Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center, Groningen, the Netherlands.
PMID:
31659485
PMCID:
PMC6328850
DOI:
10.1186/s41181-019-0055-6
No abstract available
Publication types
Editorial